Stockscreener 앱 받기
0.7663
2.11%
-0.0165
시간 외 거래:
.78
0.0137
+1.79%
Ibio Inc 주식(IBIO)의 최신 뉴스
Form 4 Ibio Inc: Gary Sender (Director) For: 14 October By Investing.com - Investing.com Canada
Form 4 Ibio Inc: Gary Sender (Director) For: 14 October By Investing.com - Investing.com South Africa
Form 4 Ibio Inc: Antonio Bernardino Guimaraes Parada (Director) For: 14 October By Investing.com - Investing.com South Africa
At $0.78 per share, 38,000 options go to iBio (IBIO) director Elizabeth Stoner. - Stock Titan
38,000 options granted to iBio (IBIO) director Alexandra Kropotova vest monthly over 12 months. - Stock Titan
A director receives 38,000 iBio (IBIO) stock options with a $0.78 exercise price. - Stock Titan
A 6.25M-share passive stake in iBio (IBIO) has one direct holder and five reporting parties. - Stock Titan
Johnson & Johnson Stock Has Surged 44%, Can Its Growth Justify the Valuation? - Insider Monkey
iBio, Inc. Common Stock (NASDAQ: IBIO) Share Price, IBIO Stock News, IBIO Share Price & Updates - Kalkine
New iBio (NASDAQ: IBIO) investor presentation goes public - Stock Titan
iBio (NASDAQ:IBIO) Stock Rating Lowered by Wall Street Zen - marketbeat.com
iBio, Inc. (IBIO) Stock Price & News - Syfe
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape By Investing.com - Investing.com South Africa
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape By Investing.com - Investing.com Canada
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape - Investing.com
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape By Investing.com - Investing.com India
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape By Investing.com - Investing.com UK
iBio (NASDAQ: IBIO) Shareholders Set to Vote on 500 Million Share Increase on October 14, 2026 - Kalkine Media
iBio (NASDAQ:IBIO) Upgraded by Wall Street Zen to Hold Rating - marketbeat.com
iBio, Inc. SEC Filing (Sep 4, 2026) - stocktitan.net
Hundreds of millions of new shares on ballot at iBio (IBIO) - Stock Titan
iBio, Inc. Common Stock (NASDAQ: IBIO) Share Price, IBIO Stock News, IBIO Share Price & Updates - kalkine.ca
iBio, Inc. (NASDAQ:IBIO) Receives Average Rating of "Buy" from Brokerages - marketbeat.com
iBio Q2 EPS Forecast Decreased by Brookline Capital Markets - MarketBeat
iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference - Yahoo Finance
Insiders Give Up US$33k As iBio Stock Drops To US$1.27 - simplywall.st
iBio Inc. (IBIO) Slides 6.6% to $1.27 as Biotech Stock Approaches Key SupportWyckoff Distribution - dars.gov.et
B. Riley Securities Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $6 - moomoo.com
iBio Advances IBIO-600 Through First Phase 1 Dose Escalation As Cash And Investments Reach $88 Million - Pulse 2.0
iBio Inc. (IBIO) Slides 6.6% to $1.27 as Biotech Stock Approaches Key SupportVolume Rate Change - dars.gov.et
iBio, Inc. Revenue Breakdown – NASDAQ:IBIO - TradingView
iBio FY2026 Net Loss Widens to $33M on Higher R&D Spending - Minichart
iBio FY 2026: Revenue $100K, Net income ($33.04M), EPS ($0.32) — 10-K Summary - tradingview.com
iBio reports $33 million loss for fiscal 2026, advances pipeline By Investing.com - Investing.com Canada
IBio Reports $33.0 Million Fiscal 2026 Net Loss as Phase 1 Advances - Moomoo
iBio Reports $33.0 Million Fiscal 2026 Net Loss as Phase 1 Advances - Quiver Quantitative
IBIO: Advanced clinical pipeline and secured funding, extending cash runway into fiscal 2028 - TradingView
iBio (NASDAQ:IBIO) Releases Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
iBio reports FY2026 net loss of $33.0M, revenue $0.1M and $88.0M cash and investments - TradingView
iBio reports $33 million loss for fiscal 2026, advances pipeline By Investing.com - Investing.com Nigeria
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - manilatimes.net
iBio Reports Fiscal 2026 Financial Results and Corporate Update Highlighting Clinical and Pipeline Progress - Quiver Quantitative
IBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - marketscreener.com
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - au.finance.yahoo.com
iBio FY26 Results: Net loss widens 80% to $33.0M, R&D up 136% - scanx.trade
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewswire
iBio (IBIO) Expected to Release Quarterly Earnings on Friday - MarketBeat
iBio (NASDAQ:IBIO) Cut to "Sell" at Wall Street Zen - MarketBeat
iBio (NYSE: IBIO) seeks 500M shares, revises equity plan for warrants - Stock Titan
iBio (IBIO) Chart: Closes 1.72% Lower at $1.43 for the Current Session; Current Setup: the Near-Term Reference Band Stretches From $1.36 to $1.50 in the Available RecordMax Pain Level - vinanet.vn
4.22%
자본화:
|
볼륨(24시간):